X
Xiaoqiang Ding
Publications - 2
Citations - 262
Xiaoqiang Ding is an academic researcher. The author has contributed to research in topics: Kidney disease & valvular heart disease. The author has an hindex of 2, co-authored 2 publications receiving 58 citations.
Papers
More filters
Journal ArticleDOI
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Michael G. Shlipak,Michael G. Shlipak,Sri Lekha Tummalapalli,Sri Lekha Tummalapalli,L. Ebony Boulware,Morgan E. Grams,Morgan E. Grams,Joachim H. Ix,Joachim H. Ix,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha,Andre Pascal Kengne,Andre Pascal Kengne,Magdalena Madero,Borislava Mihaylova,Borislava Mihaylova,Navdeep Tangri,Michael Cheung,Michel Jadoul,Wolfgang C. Winkelmayer,Sophia Zoungas,Georgi Abraham,Zanfina Ademi,Radica Z. Alicic,Ian H. de Boer,Raj Deo,Xiaoqiang Ding,Natalie Ebert,Kevin J. Fowler,Linda F. Fried,Ron T. Gansevoort,Guillermo Garcia-Garcia,Brenda R. Hemmelgarn,Jessica Lee Harding,Joanna Q. Hudson,Kunitoshi Iseki,Vasantha Jotwani,Leah S. Karliner,Andrew S. Levey,Adrian Liew,Peter J. Lin,Andrea O.Y. Luk,Verónica Martínez,Andrew E. Moran,Mai Nguyen,Gregorio T. Obrador,Donal O'Donoghue,Meda E. Pavkov,Jessie Pavlinac,Neil R. Powe,Jesse C. Seegmiller,Jenny I. Shen,Rukshana Shroff,Laura Sola,Maarten W. Taal,James Tattersall,Joseph A. Vassalotti,Matthew R. Weir,Ella Zomer +59 more
TL;DR: KDIGO held a controversies conference and a consensus emerged that CKD screening coupled with risk stratification and treatment should be implemented immediately in high-risk persons and that this should ideally occur in primary or community care settings with tailoring to the local context.
Journal ArticleDOI
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Thomas H. Marwick,Kerstin Amann,Sripal Bangalore,J. Cavalcante,David M. Charytan,Jonathan C. Craig,John S. Gill,Mark A. Hlatky,Alan G. Jardine,Ulf Landmesser,L. Kristin Newby,Charles A. Herzog,Michael Cheung,David C. Wheeler,Wolfgang C. Winkelmayer,Mark J. Sarnak,Debasish Banerjee,Carlo Briguori,Tara I. Chang,Chien Liang Chen,Christopher DeFilippi,Xiaoqiang Ding,Charles J. Ferro,Jagbir Gill,Mario Gössl,Nicole M. Isbel,Hideki Ishii,Meg Jardine,Philip A. Kalra,Günther Laufer,Krista L. Lentine,Kevin W. Lobdell,Charmaine E. Lok,Gérard M. London,Jolanta Malyszko,Patrick B. Mark,Mohamed Marwan,Yuxin Nie,Patrick S. Parfrey,Roberto Pecoits-Filho,Helen Pilmore,Wajeh Y. Qunibi,Paolo Raggi,Marcello Rattazzi,Patrick Rossignol,Josiah Ruturi,Charumathi Sabanayagam,Catherine M. Shanahan,Gautam R. Shroff,Rukshana Shroff,Angela C Webster,Daniel E. Weiner,Simon Winther,Alexander C. Wiseman,Anthony Yip,Alexander Zarbock +55 more
TL;DR: This Kidney Disease: Improving Global Outcomes (KDIGO) review of CKD and VHD seeks to improve understanding of the epidemiology, pathophysiology, diagnosis, and treatment of VHD in CKD by summarizing knowledge gaps, areas of controversy, and priorities for research.